出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/04/17 12:53:52」(JST)[Wiki en表示]
PDB rendering based on 1GRE.
|External IDs||ChEMBL: GeneCards:|
|RNA expression pattern|
Glutathione reductase (GR) also known as glutathione-disulfide reductase (GSR) is an enzyme that in humans is encoded by the GSR gene. Glutathione reductase (EC 188.8.131.52) catalyzes the reduction of glutathione disulfide (GSSG) to the sulfhydryl form glutathione (GSH), which is a critical molecule in resisting oxidative stress and maintaining the reducing environment of the cell. Glutathione reductase functions as dimeric disulfide oxidoreductase and utilizes an FAD prosthetic group and NADPH to reduce one molar equivalent of GSSG to two molar equivalents of GSH:
The glutathione reductase is conserved between all kingdoms. In bacteria, yeasts, and animals, one glutathione reductase gene is found; however, in plant genomes, two GR genes are encoded. Drosophila and Trypanosomes do not have any GR at all. In these organisms, glutathione reduction is performed by either the thioredoxin or the trypanothione system, respectively.
- 1 Function
- 2 Structure
- 3 Reaction mechanism
- 3.1 Reductive half
- 3.2 Oxidative half
- 4 Inhibition
- 5 Clinical significance
- 5.1 Deficiency
- 5.2 Connection to Favism
- 6 Monitoring glutathione reductase activity
- 7 Glutathione reductase in plants
- 8 History
- 9 Interactive pathway map
- 10 References
- 11 Further reading
Human GSR with bound glutathione and FADH
|PDB structures||RCSB PDB PDBe PDBsum|
|Gene Ontology||AmiGO / EGO|
Glutathione plays a key role in maintaining proper function and preventing oxidative stress in human cells. It can act as a scavenger for hydroxyl radicals, singlet oxygen, and various electrophiles. Reduced glutathione reduces the oxidized form of the enzyme glutathione peroxidase, which in turn reduces hydrogen peroxide (H2O2), a dangerously reactive species within the cell. In addition, it plays a key role in the metabolism and clearance of xenobiotics, acts as a cofactor in certain detoxifying enzymes, participates in transport, and regenerates antioxidants such and Vitamins E and C to their reactive forms. The ratio of GSSH/GSH present in the cell is a key factor in properly maintaining the oxidative balance of the cell, that is, it is critical that the cell maintains high levels of the reduced glutathione and a low level of the oxidized Glutathione disulfide. This narrow balance is maintained by glutathione reductase, which catalyzes the reduction of GSSG to GSH.
Glutathione reductase from human erythrocytes is a homodimer consisting of 52Kd monomers, each containing 3 domains. GR exhibits single sheet, double layered topology where an anti-parallel beta-sheet is largely exposed to the solvent on one face while being covered by random coils on the other face. This includes and NADPH-binding Domain, FAD-binding domain(s) and a dimerization domain. Each monomer contains 478 residues and one FAD molecule. GR is a thermostable protein, retaining function up to 65oC.
|1||NADPH binding to the oxidized enzyme|
|2||Reduction of FAD to FADH− anion by NADPH|
|3||Reduced FADH− anion collapses into a charge relay complex and reduces Cys58-Cys63 disulfide|
|4||Oxidized Glutathione disulfide binds to the reduced enzyme and forms a mixed disulfide with Cys58 and releases one reduced glutathione|
|5||Cys63 attacks the mixed disulfide on Cys58 to release a reduced glutathione and reform the redox active disulfide|
The action of GR proceeds through two distinct half reactions, a reductive half mechanism followed by an oxidative half. In the first half, NADPH reduces FAD present in GSR to produce a transient FADH− anion. This anion then quickly breaks a disulfide bond of Cys58 - Cys63, forming a short lived covalent bond a stable charge-transfer complex between the flavin and Cys63. The now oxidized NADP+ is released and is subsequently replaced by a new molecule of NADPH. This is the end of the so-called reductive half of the mechanism.
In the oxidative half of the meachanism, Cys63 nucleophilically attacks the nearest sulfide unit in the GSSG molecule (promoted by His467), which creates a mixed disulfide bond (GS-Cys58) and a GS− anion. His467 of GSR then protonates the GS- anion to release the first molecule of GSH. Next, Cys58 nucleophilically attacks the sulfide of Cys58, releasing a GS− anion, which, in turn, picks up a solvent proton and is released from the enzyme, thereby creating the second GSH. So, for every GSSG and NADPH, two reduced GSH molecules are gained, which can again act as antioxidants scavenging reactive oxygen species in the cell.
In vitro, glutathione reductase is inhibited by low concentrations of sodium arsenite and methylated arensate metabolites, but in vivo, significant Glutathione Reductase inhibition by sodium arsenate has only been at 10 mg/kg/day. Glutathione reductase is also inhibited by some flavanoids, a class of pigments produced by plants.
GSH is a key cellular antioxidant and plays a major role in the phase 2 metabolic clearance of electrophilic xenobiotics. The importance of the GSH pathway and enzymes that affect this delicate balance is gaining an increased level of attention in recent years. Although glutathione reductase has been an attractive target for many pharmaceuticals, there have been no successful glutathione reductase related therapeutic compounds created to date. In particular, glutathione reductase appears to be a good target for anti-malarials, as the glutathione reductase of the malaria parasite plasmodium falciparum has a significantly different protein fold than that of mammalian glutathione reductase. By designing drugs specific to p. falciparum it may be possible to selectively induce oxidative stress in the parasite, while not affecting the host.
There are two main classes of GR targeting compounds:
- Inhibitors of GSSG binding, or dimerization: Reactive electrophiles such as gold compounds, and ﬂuoronaphthoquinones.
- Drugs which use glutathione reductase to regenerate, such as redox cyclers. Two examples of these types of compounds are Methylene blue and Naphthoquinone.
Clinical trials performed in Burkina Faso have revealed mixed results when treating malaria with Naphthoquinones
In cells exposed to high levels of oxidative stress, like red blood cells, up to 10% of the glucose consumption may be directed to the pentose phosphate pathway (PPP) for production of the NADPH needed for this reaction. In the case of erythrocytes, if the PPP is non-functional, then the oxidative stress in the cell will lead to cell lysis and anemia.
Lupus is an autoimmune disorder in which patients produce an elevated quantity of antibodies that attack DNA and other cell components. In a recent study, a single nucleotide polymorphism (SNP) in the Glutathione Reductase gene was found to be highly associated with lupus in African Americans in the study. African Americans with lupus have also been shown to express less reduced glutathione in their T cells. The study's authors believe that reduced glutathione reductase activity may contribute to the increased production of reactive oxygen in African Americans with lupus.
In mice, glutathione reductase has been implicated in the oxidative burst, a component of the immune response. The oxidative burst is a defense mechanism in which neutrophils produce and release reactive oxidative species in the vicinity of bacteria or fungi to destroy the foreign cells. Glutathione Reductase deficient neutrophils were shown to produce a more transient oxidative burst in response to bacteria than neutrophils that express GR at ordinary levels. The mechanism of Glutathione Reductase in sustaining the oxidative burst is still unknown.
Glutathione reductase deficiency is a rare disorder in which the glutathione reductase activity is absent from erythrocytes, leukocytes or both. In one study this disorder was observed in only two cases in 15,000 tests for glutathione reductase deficiency performed over the course of 30 years. In the same study, glutathione reductase deficiency was associated with cataracts and favism in one patient and their family, and with severe unconjugated hyperbilirubinemia in another patient. It has been proposed that the glutathione redox system (of which glutathione reductase is apart) is almost exclusively responsible for the protecting of eye lens cells from hydrogen peroxide because these cells are deficient in catalase, the enzyme which catalyzes the breakdown of hydrogen peroxide, and the high rate of cataract incidence in glutathione reductase deficient individuals.
Some patients exhibit deficient levels of glutathione activity as a result of not consuming enough riboflavin in their diets. Riboflavin is a precursor for FAD, whose reduced form donates two electron to the disulfide bond which is present in the oxidized form of glutathione reductase in order to begin the enzyme's catalytic cycle. In 1999, a study found that 17.8% of males and 22.4% of females examined in Saudi Arabia suffered from low glutathione reductase activity due to riboflavin deficiency.
Connection to Favism
In Favism, patients lack glucose-6-phosphate dehydrogenase, an enzyme in their pentose phosphate pathway that reduces NADP+ to NADPH while catalyzing the conversion of glucose-6-phosphate to 6-phosphoglucono-δ-lactone. Glucose-6-phosphate dehydrogenase deficient individuals have less NADPH available for the reduction of oxidized glutathione via glutathione reductase. Thus their basal ratio of oxidized to reduced glutathione is significantly higher than that of patients who express glucose-6-phosphate dehydrogenase, normally, making them unable to effectively respond to high levels of reactive oxygen species, which cause cell lysis.
Monitoring glutathione reductase activity
The activity of glutathione reductase is used as indicator for oxidative stress. The activity can be monitored by the NADPH consumption, with absorbance at 340 nm, or the formed GSH can be visualized by Ellman's reagent. Alternatively the activity can be measured using roGFP (redox-sensitive Green Fluorescent Protein).
Glutathione reductase in plants
As it does in human cells, glutathione reductase helps to protect plant cells from reactive oxygen species. In plants, reduced glutathione participates in the glutathione-ascorbate cycle in which reduced glutathione reduces dehydroascorbate, a reactive byproduct of the reduction of hydrogen peroxide. In particular, Glutathione reductase contributes to plants' response to abiotic stress. The enzyme's activity has been shown to be modulated in response to metals, metalloids, salinity, drought, UV radiation and heat induced stress.
Glutathione reductase was first purified in 1955 at Yale by E. Racker. Racker also identified NADPH as the primary electron donor for the enzyme. Later groups confirmed the presence of FAD and the thiol group, and an initial mechanism was suggested for the mechanism in 1965. The initial (low resolution) structure of glutathione reductase was solved in 1977. This was quickly followed by a 3Å structure by Shulze et al. in 1978. Glutathione reductase has been studied exhaustively since these early experiments, and is subsequently one of the most well characterized enzymes to date.
Interactive pathway map
Interactive pathway can be found here: pathway map
- Deponte M (May 2013). "Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes". Biochim. Biophys. Acta 1830 (5): 3217–66. doi:10.1016/j.bbagen.2012.09.018. PMID 23036594.
- Meister A (November 1988). "Glutathione metabolism and its selective modification". J. Biol. Chem. 263 (33): 17205–8. PMID 3053703.
- Mannervik B (August 1987). "The enzymes of glutathione metabolism: an overview". Biochem. Soc. Trans. 15 (4): 717–8. PMID 3315772.
- Kanzok SM, Fechner A, Bauer H, Ulschmid JK, Müller HM, Botella-Munoz J, Schneuwly S, Schirmer R, Becker K (2001). "Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster". Science 291 (5504): 643–6. doi:10.1126/science.291.5504.643. PMID 11158675. CS1 maint: Multiple names: authors list (link)
- Krauth-Siegel RL, Comini MA (2008). "Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism". Biochim Biophys Acta 1780 (11): 1236–48. doi:10.1016/j.bbagen.2008.03.006. PMID 18395526.
- Grisham,, Reginald H. Garrett,... Charles M. (2005). Biochemistry (3rd ed.). Belmont, CA: Thomson Brooks/Cole. ISBN 0534490336.
- Masella R, Di Benedetto R, Varì R, Filesi C, Giovannini C (October 2005). "Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes". J. Nutr. Biochem. 16 (10): 577–86. doi:10.1016/j.jnutbio.2005.05.013. PMID 16111877. CS1 maint: Multiple names: authors list (link)
- Dym O, Eisenberg D (September 2001). "Sequence-structure analysis of FAD-containing proteins". Protein Sci. 10 (9): 1712–28. doi:10.1110/ps.12801. PMC: 2253189. PMID 11514662.
- Berkholz DS, Faber HR, Savvides SN, Karplus PA (October 2008). "Catalytic cycle of human glutathione reductase near 1 A resolution". J. Mol. Biol. 382 (2): 371–84. doi:10.1016/j.jmb.2008.06.083. PMC: 2593804. PMID 18638483. CS1 maint: Multiple names: authors list (link)
- Rodríguez VM, Del Razo LM, Limón-Pacheco JH, Giordano M, Sánchez-Peña LC, Uribe-Querol E, Gutiérrez-Ospina G, Gonsebatt ME (March 2005). "Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver". Toxicol. Sci. 84 (1): 157–66. doi:10.1093/toxsci/kfi057. PMID 15601678. CS1 maint: Multiple names: authors list (link)
- Elliott AJ, Scheiber SA, Thomas C, Pardini RS (October 1992). "Inhibition of glutathione reductase by flavonoids. A structure-activity study". Biochem. Pharmacol. 44 (8): 1603–8. doi:10.1016/0006-2952(92)90478-2. PMID 1329770. CS1 maint: Multiple names: authors list (link)
- Sarma GN, Savvides SN, Becker K, Schirmer M, Schirmer RH, Karplus PA (May 2003). "Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development". J. Mol. Biol. 328 (4): 893–907. doi:10.1016/s0022-2836(03)00347-4. PMID 12729762. CS1 maint: Multiple names: authors list (link)
- Buchholz K, Schirmer RH, Eubel JK, Akoachere MB, Dandekar T, Becker K, Gromer S (January 2008). "Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum". Antimicrob. Agents Chemother. 52 (1): 183–91. doi:10.1128/AAC.00773-07. PMC: 2223905. PMID 17967916. CS1 maint: Multiple names: authors list (link)
- Müller T, Johann L, Jannack B, Brückner M, Lanfranchi DA, Bauer H, Sanchez C, Yardley V, Deregnaucourt C, Schrével J, Lanzer M, Schirmer RH, Davioud-Charvet E (August 2011). "Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites". J. Am. Chem. Soc. 133 (30): 11557–71. doi:10.1021/ja201729z. PMID 21682307. CS1 maint: Multiple names: authors list (link)
- Deponte M, Urig S, Arscott LD, Fritz-Wolf K, Réau R, Herold-Mende C, Koncarevic S, Meyer M, Davioud-Charvet E, Ballou DP, Williams CH, Becker K (May 2005). "Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase". J. Biol. Chem. 280 (21): 20628–37. doi:10.1074/jbc.M412519200. PMID 15792952. CS1 maint: Multiple names: authors list (link)
- Deponte M (May 2013). "Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes". Biochim. Biophys. Acta 1830 (5): 3217–66. doi:10.1016/j.bbagen.2012.09.018. PMID 23036594.
- Champe PC, Harvey RA, Ferrier DR (2008). Biochemistry (fourth ed.). Lippincott Williams and Wilkins. ISBN 978-0-7817-6960-0. CS1 maint: Multiple names: authors list (link)
- Ramos PS, Oates JC, Kamen DL, Williams AH, Gaffney PM, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Jacob CO, Tsao BP, Alarcón GS, Brown EE, Edberg JC, Petri MA, Ramsey-Goldman R, Reveille JD, Vilá LM, James JA, Guthridge JM, Merrill JT, Boackle SA, Freedman BI, Scofield RH, Stevens AM, Vyse TJ, Criswell LA, Moser KL, Alarcón-Riquelme ME, Langefeld CD, Harley JB, Gilkeson GS (June 2013). "Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry". J. Rheumatol. 40 (6): 842–9. doi:10.3899/jrheum.120989. PMC: 3735344. PMID 23637325. CS1 maint: Multiple names: authors list (link)
- Gergely P, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A (January 2002). "Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus". Arthritis Rheum. 46 (1): 175–90. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H. PMC: 4020417. PMID 11817589. CS1 maint: Multiple names: authors list (link)
- Yan J, Meng X, Wancket LM, Lintner K, Nelin LD, Chen B, Francis KP, Smith CV, Rogers LK, Liu Y (March 2012). "Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps". J. Immunol. 188 (5): 2316–27. doi:10.4049/jimmunol.1102683. PMC: 3480216. PMID 22279102. CS1 maint: Multiple names: authors list (link)
- Kamerbeek NM, Zwieten R, Boer M, Morren G, Vuil H, Bannink N, Lincke C, Dolman KM, Becker K, Schirmer RH, Gromer S, Roos D (2007). "Molecular basis of glutathione reductase deficiency in human blood cells". Blood 109 (8): 3560–3566. doi:10.1182/blood-2006-08-042531. PMID 17185460. CS1 maint: Multiple names: authors list (link)
- Roos D, Weening RS, Voetman AA, van Schaik ML, Bot AA, Meerhof LJ, Loos JA (May 1979). "Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency". Blood 53 (5): 851–66. PMID 435643. CS1 maint: Multiple names: authors list (link)
- Warsy AS, el-Hazmi MA (November 1999). "Glutathione reductase deficiency in Saudi Arabia". East. Mediterr. Health J. 5 (6): 1208–12. PMID 11924113.
- Cappellini MD, Fiorelli G (January 2008). "Glucose-6-phosphate dehydrogenase deficiency". Lancet 371 (9606): 64–74. doi:10.1016/S0140-6736(08)60073-2. PMID 18177777.
- Smith IK, Vierheller TL, Thorne CA (1988). "RAssay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis(2-nitrobenzoic acid)". Anal Biochem 175 (2): 408–13. doi:10.1016/0003-2697(88)90564-7. PMID 3239770. CS1 maint: Multiple names: authors list (link)
- Marty L, Siala W, Schwarzländer M, Fricker MD, Wirtz M, Sweetlove LJ, Meyer Y, Meyer AJ, Reichheld JP, Hell R. (2009). "The NADPH-dependent thioredoxin system constitutes a functional backup for cytosolic glutathione reductase in Arabidopsis". Proc Natl Acad Sci U S A 106 (22): 9109–14. doi:10.1073/pnas.0900206106. PMC: 2690020. PMID 19451637. CS1 maint: Multiple names: authors list (link)
- Gill SS, Anjum NA, Hasanuzzaman M, Gill R, Trivedi DK, Ahmad I, Pereira E, Tuteja N (September 2013). "Glutathione and glutathione reductase: a boon in disguise for plant abiotic stress defense operations". Plant Physiol. Biochem. 70: 204–12. doi:10.1016/j.plaphy.2013.05.032. PMID 23792825. CS1 maint: Multiple names: authors list (link)
- Racker E (December 1955). "Glutathione reductase from bakers' yeast and beef liver". J. Biol. Chem. 217 (2): 855–65. PMID 13271446.
- Massey V, Williams CH (November 1965). "On the reaction mechanism of yeast glutathione reductase". J. Biol. Chem. 240 (11): 4470–80. PMID 4378936.
- Mapson LW, Isherwood FA (January 1963). "Glutathione reductase from germinated peas". Biochem. J. 86: 173–91. PMC: 1201730. PMID 13932735.
- Schulz GE, Schirmer RH, Sachsenheimer W, Pai EF (May 1978). "The structure of the flavoenzyme glutathione reductase". Nature 273 (5658): 120–4. doi:10.1038/273120a0. PMID 25387. CS1 maint: Multiple names: authors list (link)
- Sinet PM, Bresson JL, Couturier J, Laurent C, Prieur M, Rethoré MO, Taillemite JL, Toudic D, Jérome H, Lejeune J (1977). "[Possible localization of the glutathione reductase (EC 184.108.40.206) on the 8p21 band]". Ann. Genet. (in French) 20 (1): 13–7. PMID 302667. CS1 maint: Multiple names: authors list (link)
- Krohne-Ehrich G, Schirmer RH, Untucht-Grau R (1978). "Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide". Eur. J. Biochem. 80 (1): 65–71. doi:10.1111/j.1432-1033.1977.tb11856.x. PMID 923580. CS1 maint: Multiple names: authors list (link)
- Loos H, Roos D, Weening R, Houwerzijl J (1976). "Familial deficiency of glutathione reductase in human blood cells". Blood 48 (1): 53–62. PMID 947404. CS1 maint: Multiple names: authors list (link)
- Tutic M, Lu XA, Schirmer RH, Werner D (1990). "Cloning and sequencing of mammalian glutathione reductase cDNA". Eur. J. Biochem. 188 (3): 523–8. doi:10.1111/j.1432-1033.1990.tb15431.x. PMID 2185014. CS1 maint: Multiple names: authors list (link)
- Palmer EJ, MacManus JP, Mutus B (1990). "Inhibition of glutathione reductase by oncomodulin". Arch. Biochem. Biophys. 277 (1): 149–54. doi:10.1016/0003-9861(90)90563-E. PMID 2306116. CS1 maint: Multiple names: authors list (link)
- Arnold HH, Heinze H (1990). "Treatment of human peripheral lymphocytes with concanavalin A activates expression of glutathione reductase". FEBS Lett. 267 (2): 189–92. doi:10.1016/0014-5793(90)80922-6. PMID 2379581.
- Karplus PA, Schulz GE (1987). "Refined structure of glutathione reductase at 1.54 A resolution". J. Mol. Biol. 195 (3): 701–29. doi:10.1016/0022-2836(87)90191-4. PMID 3656429.
- Pai EF, Schulz GE (1983). "The catalytic mechanism of glutathione reductase as derived from x-ray diffraction analyses of reaction intermediates". J. Biol. Chem. 258 (3): 1752–7. PMID 6822532.
- Krauth-Siegel RL, Blatterspiel R, Saleh M, Schiltz E, Schirmer RH, Untucht-Grau R (1982). "Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain". Eur. J. Biochem. 121 (2): 259–67. doi:10.1111/j.1432-1033.1982.tb05780.x. PMID 7060551. CS1 maint: Multiple names: authors list (link)
- Thieme R, Pai EF, Schirmer RH, Schulz GE (1982). "Three-dimensional structure of glutathione reductase at 2 A resolution". J. Mol. Biol. 152 (4): 763–82. doi:10.1016/0022-2836(81)90126-1. PMID 7334521. CS1 maint: Multiple names: authors list (link)
- Huang J, Philbert MA (1995). "Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells". Brain Res. 680 (1–2): 16–22. doi:10.1016/0006-8993(95)00209-9. PMID 7663973.
- Savvides SN, Karplus PA (1996). "Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor". J. Biol. Chem. 271 (14): 8101–7. doi:10.1074/jbc.271.14.8101. PMID 8626496.
- Nordhoff A, Tziatzios C, van den Broek JA, Schott MK, Kalbitzer HR, Becker K, Schubert D, Schirmer RH (1997). "Denaturation and reactivation of dimeric human glutathione reductase--an assay for folding inhibitors". Eur. J. Biochem. 245 (2): 273–82. doi:10.1111/j.1432-1033.1997.00273.x. PMID 9151953. CS1 maint: Multiple names: authors list (link)
- Stoll VS, Simpson SJ, Krauth-Siegel RL, Walsh CT, Pai E' (1997). "Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity". Biochemistry 36 (21): 6437–47. doi:10.1021/bi963074p. PMID 9174360. CS1 maint: Multiple names: authors list (link)
- Becker K, Savvides SN, Keese M, Schirmer RH, Karplus PA (1998). "Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers". Nat. Struct. Biol. 5 (4): 267–71. doi:10.1038/nsb0498-267. PMID 9546215. CS1 maint: Multiple names: authors list (link)
- Kelner MJ, Montoya MA (2000). "Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence". Biochem. Biophys. Res. Commun. 269 (2): 366–8. doi:10.1006/bbrc.2000.2267. PMID 10708558.
- Qanungo S, Mukherjea M (2001). "Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues". Mol. Cell. Biochem. 215 (1–2): 11–9. doi:10.1023/A:1026511420505. PMID 11204445.
- Berry Y, Truscott RJ (2001). "The presence of a human UV filter within the lens represents an oxidative stress". Exp. Eye Res. 72 (4): 411–21. doi:10.1006/exer.2000.0970. PMID 11273669.
- Rhie G, Shin MH, Seo JY, Choi WW, Cho KH, Kim KH, Park KC, Eun HC, Chung JH (2001). "Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo". J. Invest. Dermatol. 117 (5): 1212–7. doi:10.1046/j.0022-202x.2001.01469.x. PMID 11710935. CS1 maint: Multiple names: authors list (link)
- Zatorska A, Józwiak Z (2003). "Involvement of glutathione and glutathione-related enzymes in the protection of normal and trisomic human fibroblasts against daunorubicin". Cell Biol. Int. 26 (5): 383–91. doi:10.1006/cbir.2002.0861. PMID 12095224.
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. ヘキソースリン酸側路およびグルタチオン代謝疾患（グルコース-6-リン酸脱水素酵素欠損症を除く） disorders of the hexose monophosphate shunt and glutathione metabolism other than glucose 6 phosphate dehydrogenase deficiency
- 2. 免疫不全症を引き起こすミエロペルオキシダーゼ欠損症および酵素白血球欠損症 myeloperoxidase deficiency and other enzymatic wbc defects causing immunodeficiency
- 3. 不安定ヘモグロビン変異体 unstable hemoglobin variants
- 4. メトヘモグロビン血症の遺伝学および病因 genetics and pathogenesis of methemoglobinemia
- 5. 糖尿病合併症の予防におけるアルドース還元酵素阻害剤 aldose reductase inhibitors in the prevention of diabetic complications
- Nitric oxide mediates isoflavone accumulation and the antioxidant system enhancement in soybean sprouts.
- Jiao C1, Yang R1, Zhou Y1, Gu Z2.
- Food chemistry.Food Chem.2016 Aug 1;204:373-80. doi: 10.1016/j.foodchem.2016.02.147. Epub 2016 Feb 26.
- In this study, we investigated the relationships between endogenous NO signal transduction pathways, the antioxidant system and isoflavone accumulation induced by UV-B radiation in soybean sprouts. Results showed that UV-B-triggered NO generation induced isoflavone accumulation by up-regulating the
- PMID 26988515
- Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients.
- El-Ansary A1.
- Data in brief.Data Brief.2016 Feb 15;7:111-6. doi: 10.1016/j.dib.2016.02.025. eCollection 2016.
- This work demonstrates data of multiple regression analysis between nine biomarkers related to glutamate excitotoxicity and impaired detoxification as two mechanisms recently recorded as autism phenotypes. The presented data was obtained by measuring a panel of markers in 20 autistic patients aged 3
- PMID 26933667
- Arabidopsis Root-Abundant Cytosolic Methionine Sulfoxide Reductase B Genes MsrB7 and MsrB8 are Involved in Tolerance to Oxidative Stress
- Li Chia-Wen,Lee Shu-Hong,Chieh Pei-Shan [他]
- Plant and Cell Physiology 53(10), 1707-1719, 2012-10-00
- NAID 40019457178
- Protective effect of sulphoraphane against oxidative stress mediated toxicity induced by CuO nanoparticles in mouse embryonic fibroblasts BALB 3T3
- Akhtar Mohd Javed,MaqusoodAhamed,Fareed Mohd [他],ALROKAYAN Salman A.,KUMAR Sudhir
- Journal of toxicological sciences 37(1), 139-148, 2012-02-01
- … CuO NPs were also found to induce oxidative stress in dose-dependent manner indicated by induction of reactive oxygen species (ROS) and lipid peroxidation (LPO) and depletion of glutathione and glutathione reductase. … Moreover, we found that co-treatment of another antioxidant N-acetyl-cysteine (NAC) (2 mM) also significantly attenuated glutathione depletion caused by CuO NPs but protection from the loss of cell viability due to CuO NPs exposure was not significant. …
- NAID 10030037638
- In a similar manner, levels of GSH and glutathione reductase that were defense mechanisms against ROS damage were found to be higher in quercetin groups, which indicates that quercetin treatment decreases oxidative stress ...
- Buy Glutathione reductase antibodies from Santa Cruz. Glutathione reductase products include 7 monoclonal antibodies, 3 polyclonal antibodies and si/shRNAs. ... HOVERcruz ,を紹介します。Glutathione reductase Antibodiesを ...
- glutathione, GSH
- γ-グルタミルシステイニルグリシン γ-glutamylcysteinylglycine、5-L-グルタミルL-システイニルグリシン
- グルタチオンは、細胞内に 0.5-10 mMという比較的高濃度で存在する。一方細胞外の濃度はその1/100から1/1000程度である。グルタチオンには還元型 (GSH) と酸化型 (glutathione disulfide, GSSG)が存在する。酸化型は、二分子の還元型グルタチオンがジスルフィド結合によってつながった分子である。細胞内のグルタチオンは、通常、ほとんど（98%以上）が還元型であり、この状態はグルタチオン還元酵素によって維持されている。
- グルタチオンは'グルタミン酸、システイン、グリシンが、この順番でペプチド結合したトリペプチドである (L-γ-glutamyl-L-cysteinyl-glycine)。ただし、グルタミン酸とシステインの結合は通常のペプチド結合とは異なり、グルタミン酸側鎖のγ-カルボキシ基とシステイン主鎖のα-アミノ基からなる（γ-グルタミル結合）。このためグルタチオンは、ペプチドでありながら、ほとんどのプロテアーゼに対して耐性であり、分解されない。グルタチオンを直接分解できる酵素はγ-グルタミルトランスペプチターゼや、その近縁のごく限られた酵素のみである。